ClinicalTrials.gg
Active, not recruitingNCT05192408Updated Dec 22, 2023

Multi-component Intervention for Reducing Fear of Falling in Community-dwelling Older Adults

An interventional study of Multi-component intervention and Usual Care in Fear of Falling, sponsored by National Healthcare Group Polyclinics. Active, not recruiting at 1 site in Singapore. Open to participants aged 65 Years to 99 Years. Per ClinicalTrials.gov, last updated 2023-12-22.

Sponsored by National Healthcare Group Polyclinics · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jun 2024, 2 years 5 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
420
Allocation
Randomized
Ages
65 Years to 99 Years
Sex
All
01

Study summary

In the short term, the study will provide insight into the effectiveness of multi-component intervention for reducing Fear of falling (FoF) in community-dwelling older adults. Effective interventions will be incorporated into existing programs for frailty and falls prevention in primary care. Reducing FoF will break the cycle of physical activity restriction, functional decline and further falls in older adults. Long term potential benefits include improving the health status of older adults and thus reducing healthcare utilization.

The primary aim is to compare the effectiveness of a multi-component intervention comprising exercise recommendations, cognitive behavioural therapy (CBT) components and motivational interviewing (MI) based telephone review against usual care for reducing Fear of Falling (FoF) in community- dwelling older adults.

Secondary aims include to compare the effectiveness of the multi-component intervention against usual care for increasing physical activity and reducing falls in community- dwelling older adults.

The hypothesis is that the multi-component intervention will be more effective as compared to usual care for reducing FoF and falls and increasing physical activity in community- dwelling older adults.

Read the detailed description

In the short term, the study will provide insight into the effectiveness of multi-component intervention for reducing Fear of falling (FoF) in community-dwelling older adults. Effective interventions will be incorporated into existing programs for frailty and falls prevention in primary care. Reducing FoF will break the cycle of physical activity restriction, functional decline and further falls in older adults. Long term potential benefits include improving the health status of older adults and thus reducing healthcare utilization.

The primary aim is to compare the effectiveness of a multi-component intervention comprising exercise recommendations, cognitive behavioural therapy (CBT) components and motivational interviewing (MI) based telephone review against usual care for reducing Fear of Falling (FoF) in community- dwelling older adults.

Secondary aims include to compare the effectiveness of the multi-component intervention against usual care for increasing physical activity and reducing falls in community- dwelling older adults.

The hypothesis is that the multi-component intervention will be more effective as compared to usual care for reducing FoF and falls and increasing physical activity in community- dwelling older adults.

Sample size was calculated with reference to effect sizes from meta-analyses where effect sizes of 0.28 and 0.33 were found.

The sample size calculation was based on effect size of 0.3 difference in FoF between the intervention and comparator groups; with power of 80% and significance level of 0.05, 175 patients will be needed in each group. Assuming attrition rate of 20%, 210 participants in each group, or a total of 420 participants, would be needed.

Recruitment procedures Recruitment will take place at all National Healthcare Group Polyclinics over a period of 12 months.

All healthcare staff including doctors, nurses, physiotherapists and care coordinators (CCs) in recruiting clinics will be briefed about the study and inclusion and exclusion criteria. Potential participants will be recruited on a case encounter basis when they attend at the clinics for follow-up visits. The above-mentioned healthcare staff will refer potential participants who meet the inclusion criteria to any of the study team members. Study team members who encounter suitable potential participants will refer them to another study team member in clinic for recruitment if available, i.e., nurses in study team may cross refer their patients to each other for recruitment.

Study team members proficient in potential participants' language will explain the study and clarify any doubts using the Participant Information Sheet, take written informed consent and administer the baseline questionnaire.

Data Collection Tools III) Fear of falling (FoF) will be screened using the Single Question on FoF and Activity Restriction (SQ-FAR) and measured using the Short Falls Efficacy Scale - International (FES-I) The SQ-FAR is a single question 'Are you afraid of falling?' used as a screening tool for FoF. It was found to have moderate agreement of 87.8% (Kappa=0.57) with the Falls Efficacy Scale-International (FES-I) in community dwelling adults aged 65 to 70 years old. Responses include 'no', 'yes' and 'yes, a lot', 'yes' and 'yes, a lot' indicate presence of FoF.

The Short FES-I is a 7-item measure of "fear of falling" and has been demonstrated to have good reliability and validity. It was also evaluated in Malaysia and showed good internal consistency, test-retest reliability, construct validity, and responsiveness, with Cronbach's alpha of 0.905 and intraclass correlation coefficient 0.997 for the English version. Scores are calculated by totaling responses for each item, with a range from minimum 7 (no concern about falling) to maximum 28 (severe concern about falling). 7 to 8 points indicates low concern, 9 to 13 indicates moderate concern and 14 to 28 indicates high concern.

IV) Physical Activity levels will be measured using the Incidental and Planned Exercise Questionnaire: Weekly Average (IPEQ -WA) The IPEQ consists of 10 questions which measure type and amount of physical activity and provides estimates of the frequency and duration of planned exercise and day-to-day activities. Validation in a population of older adults showed that IPAQ-WA had excellent test-retest reliability, with intraclass correlation coefficient 0.87 and was able to discriminate differences in physical activity levels between groups differentiated by sex, age and fall risk factors. Total time spent is summed across all components and expressed as hours per week. The score is derived from multiplying frequency score and duration score to create a total duration for the week score.

Statistical and analytical plans Demographic and clinical data, falls, FoF scores and (IPEQ-WA) scores will be reported using descriptive statistics. Paired t-test will be used to compared the differences in FoF scores, number of falls and IPEQ-WA scores pre and post intervention. Independent t-test will be used to compare differences in FoF score, number of falls and IPEQ-WA scores in intervention group and comparator group at 3 months and 6 months post intervention.

Ethical considerations Informed Consent Attending healthcare professionals will refer eligible participants to members of the study team on the day of the clinic visit. Trained study team members proficient in potential participants' language will explain the study and clarify any doubts using the Participant Information Sheet. Participants will be given the information sheet about the research study and informed that they could withdraw from the study anytime. The contact details of the PI and DSRB would be given to them to allow them to raise any queries regarding the study.

Potential participants will be given adequate time to consider before making a decision whether or not to participate. If the individual fulfils the inclusion criteria and agrees for research participation, written consent will be taken.

Confidentiality of Data and Patient Records Hard copy data will be stored in designated locked cabinet(s) or room(s). Electronic data will be stored in a secured computer that is password protected. All hard copy or electronic data will be accessible to authorized study team members only.

02

Conditions studied

  • Fear of Falling
03

In context

Lead sponsor

National Healthcare Group Polyclinics is the lead sponsor of 9 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults aged 65 and above
  • Followed up at National Healthcare Group Polyclinics for any chronic condition
  • Able to communicate in English, Mandarin, Malay
  • Reports Fear of falling as screened by single question

Exclusion criteria

Exclusion Criteria:

  • Unable to agree to participation e.g., due to cognitive impairment
  • Unable or unsafe to participate in any exercise as determined by clinician e.g., terminal illness, uncontrolled hypertension, immobility
  • Unable to participate in telephone sessions e.g., due to hearing impairment
  • Known psychiatric condition on treatment
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
420 participants (estimated)

Study arms

  • Experimental
    Multi-component intervention

    Individual intervention will comprise: 1. Cognitive- behavioral therapy (CBT) which includes: - Behavioural activation, cognitive restructuring, promotion of safety, relaxation techniques 2. Exercise recommendation utilizing current Exercise in older adults Patient Education Materials (PEMs) and videos, tailored based on frailty level and readiness to progress - Components include balance and strength 3. Use of motivational interviewing (MI) techniques for goal setting There will be 4 sessions in total. Initial sessions will be carried out face to face or via videoconferencing platform if participant prefers due to ongoing COVID-19 pandemic. Subsequent sessions will be carried out via telephone. Initial sessions will last around 30 minutes and subsequent sessions will last 15 to 30 minutes.

    Behavioral: Multi-component intervention

  • Other
    Usual Care

    Patient Education Materials (PEMs) on: 1. Exercise in older adults (Stay Active, Stay Strong and Stay Steady) - 3 different levels tailored to frailty level and for progression 2. Falls prevention 3. FoF

    Other: Usual Care

Interventions

  • BehavioralMulti-component intervention

    Individual intervention will comprise: 1. Cognitive- behavioral therapy (CBT) which includes: - Behavioural activation, cognitive restructuring, promotion of safety, relaxation techniques 2. Exercise recommendation utilizing current Exercise in older adults Patient Education Materials (PEMs) and videos, tailored based on frailty level and readiness to progress - Components include balance and strength 3. Use of motivational interviewing (MI) techniques for goal setting There will be 4 sessions in total. Initial sessions will be carried out face to face or via videoconferencing platform if participant prefers due to ongoing COVID-19 pandemic. Subsequent sessions will be carried out via telephone.

  • OtherUsual Care

    Patient Education Materials

06

What researchers measure

Primary outcomes

  1. Fear of Falling (FoF)

    FoF as measured by short FES-I

    Time frame: 3 months

Secondary outcomes

  1. Number of falls

    Number of falls

    Time frame: 3 months

  2. Physical Activity

    Physical Activity as measured by IPEQ-WA

    Time frame: 3 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2022 (actual). Primary completion is estimated for Jun 2024, 29 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2021
First posted
Jan 14, 2022
StartActual
Jan 3, 2022
Primary completionEst.
Jun 2024
CompletionEst.
Jun 2024
Last update
Dec 22, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05192408
Lead sponsor
National Healthcare Group Polyclinics
Responsible party
Sponsor
First posted
Jan 14, 2022
Start date
Jan 3, 2022
Primary completion
Jun 2024 (estimated)
Completion
Jun 2024 (estimated)
Last update
Dec 22, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion